Delcath Systems logo

Vice President, Marketing

Delcath Systems

Any City, USOnsitePosted 1 day ago
Full TimeDirector & AboveCommercial & Pharma SalesMedical Device
Original posting ↗

Summary

The VP of Marketing will report directly to Delcath's Chief Commercial Officer and serve as the senior-most marketing leader in the organization, owning brand strategy for HEPZATO KIT, market access/reimbursement marketing support, sales enablement, medical communications alignment, and patient advocacy. This leader will be responsible for professionalizing the marketing function, including agency management, omnichannel execution, and building the data infrastructure (claims/EHR) needed to measure market impact and inform strategy.

Job description

Position Summary

The VP of Marketing will report directly to Delcath's Chief Commercial Officer and serve as the senior-most marketing leader in the organization, owning brand strategy for HEPZATO KIT, market access/reimbursement marketing support, sales enablement, medical communications alignment, and patient advocacy. This leader will be responsible for professionalizing the marketing function, including agency management, omnichannel execution, and building the data infrastructure (claims/EHR) needed to measure market impact and inform strategy.

Key Responsibilities

  • Own overall marketing strategy and brand plan for HEPZATO KIT, aligned to corporate and commercial goals.
  • Rebuild and right-size the marketing organization; assess current team structure, roles, and capabilities, and hire/develop talent as needed.
  • Lead management of external agency partners (OHMA/Omnicom, Area 23, and others as needed), including scope, contracting (SOWs), and performance accountability.
  • Direct market access marketing support in close partnership with market access/reimbursement leadership, including provider and hospital education on coding, billing, and reimbursement pathways.
  • Build the company's marketing data capability, working with claims and EHR data sources to identify candidate patients, measure market penetration, and inform resource allocation.
  • Own sales enablement: field-facing detail aids, CLM/digital tools, leave-behinds, conference strategy, and KOL development.
  • Direct omnichannel execution across personal and non-personal promotion, including point-of-care marketing, HCP portal/website, programmatic and email, and peer-to-peer/medical communications.
  • Lead patient advocacy strategy and relationships with patient advocacy organizations.
  • Oversee development and deployment of real-world evidence and patient testimonial content, in partnership with medical affairs.
  • Serve as a key member of the commercial leadership team, partnering closely with the Chief Commercial Officer, sales leadership, market access, and medical affairs.
  • Establish marketing budget, KPIs, and reporting cadence to demonstrate ROI and inform ongoing investment decisions.

Candidate Profile

  • 10+ years of progressive pharmaceutical/biotech marketing experience, including 3+ years in a VP or senior marketing leadership role.
  • Direct experience marketing a rare or ultra-rare disease product, or another product with significant reimbursement/market access complexity.
  • Demonstrated experience managing external agencies, including selection, contracting, and performance management.
  • Strong understanding of specialty pharmaceutical reimbursement dynamics (e.g., buy-and-bill, 340B, transitional pass-through payment status, coding/coverage pathways).
  • Track record of building or scaling a marketing function, including team structure and process, in a small or resource-constrained commercial organization.
  • Experience directing omnichannel marketing execution, including digital, point-of-care, and field-facing content.
  • Comfortable operating with limited data infrastructure and working cross-functionally to build claims/EHR-based measurement capability.
  • Executive presence and communication skills; ability to operate as a strategic partner to the CCO and commercial leadership team.

Preferred

  • Oncology or interventional radiology commercial experience.
  • Experience with patient advocacy organization partnerships.
  • Experience in a company navigating a reimbursement status transition (e.g., loss of pass-through/orphan pricing status).

Requirements

  • 10+ years of progressive pharmaceutical/biotech marketing experience
  • 3+ years in a VP or senior marketing leadership role
  • Direct experience marketing a rare or ultra-rare disease product or product with significant reimbursement/market access complexity
  • Demonstrated experience managing external agencies including selection, contracting, and performance management
  • Strong understanding of specialty pharmaceutical reimbursement dynamics (buy-and-bill, 340B, pass-through payment, coding/coverage pathways)
  • Track record of building or scaling a marketing function in a small or resource-constrained commercial organization
  • Experience directing omnichannel marketing execution including digital, point-of-care, and field-facing content
  • Comfortable operating with limited data infrastructure and building claims/EHR-based measurement capability
  • Executive presence and communication skills
  • Preferred: Oncology or interventional radiology commercial experience
  • Preferred: Experience with patient advocacy organization partnerships
  • Preferred: Experience navigating a reimbursement status transition

Company overview

Delcath Systems is a specialty pharmaceutical and medical device company focused on innovative interventional oncology treatments. The company specializes in developing and commercializing percutaneous hepatic perfusion (PHP) therapy for patients with primary and metastatic liver cancers. Delcath's flagship product is the HEPZATO KIT (melphalan for injection/hepatic delivery system), which delivers high-dose chemotherapy directly to the liver while minimizing systemic exposure. This targeted approach allows for higher drug concentrations at the tumor site with reduced systemic side effects. The company's proprietary technology platform enables regional delivery of therapeutic agents to specific organs, representing a significant advancement in the treatment of liver-dominant cancers. Delcath operates as a publicly traded company on NASDAQ under the ticker symbol DCTH, with its corporate headquarters located in New York City. The company's innovative approach to liver cancer treatment addresses a significant unmet medical need for patients with limited therapeutic options.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.